| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $119K | — | +27.2% |
| R&D Expense | $2.8M | — | +160.4% |
| SG&A Expense | $1.2M | — | +7.3% |
| Operating Income | -$3.8M | — | -84.2% |
| Pre-tax Income | -$3.7M | — | -96.9% |
| Income Tax | $200 | — | +0.0% |
| Net Income | -$3.7M | — | -96.9% |
| EPS (Basic) | -$0.54 | — | -54.3% |
| EPS (Diluted) | -$0.54 | — | -54.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.0M | -3.7% | +49.5% |
| Current Assets | $25.2M | +49.6% | +24.2% |
| Total Assets | $25.4M | +49.1% | +23.7% |
| Current Liabilities | $2.5M | -0.0% | +94.5% |
| Total Liabilities | $2.5M | -0.0% | +94.5% |
| Stockholders' Equity | $22.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.3M | — | -14.6% |
| Investing Cash Flow | -$9.9M | — | -1022.8% |
| Financing Cash Flow | $12.0M | — | — |
| +18.9% |